BH3 Mimetics in Hematologic Malignancies

BH3 Mimetics in Hematologic Malignancies

Hematologic malignancies (HM) comprise diverse cancers of lymphoid and myeloid origin, including lymphomas (approx. 40%), chronic lymphocytic leukemia (CLL, approx. 15%), multiple myeloma (MM, approx. 15%), acute myeloid leukemia (AML, approx. 10%), and many other diseases. Despite considerable impr...

Full description

Bibliographic Details
Main Authors: Pavel Klener, Dana Sovilj, Nicol Renesova, Ladislav Andera
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
apoptosis
BH3 mimetics
venetoclax
hematologic malignancies
targeted therapy
resistance
Online Access:https://www.mdpi.com/1422-0067/22/18/10157

Internet

https://www.mdpi.com/1422-0067/22/18/10157

Similar Items